1	This	_	_	DT	_	_	_	_	_
2	series	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	25	_	_	CD	_	_	_	_	_
5	articles	_	_	NNS	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	22	_	_	CD	_	_	_	_	_
8	original	_	_	JJ	_	_	_	_	_
9	articles	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	3	_	_	CD	_	_	_	_	_
12	reviews	_	_	NNS	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	presented	_	_	VBN	_	_	_	_	_
16	by	_	_	IN	_	_	_	_	_
17	international	_	_	JJ	_	_	_	_	_
18	leaders	_	_	NNS	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	bioinformatics	_	_	NNS	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	biostatistics	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	original	_	_	JJ	_	_	_	_	_
3	series	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	articles	_	_	NNS	_	_	_	_	_
6	details	_	_	VBZ	_	_	_	_	_
7	emerging	_	_	VBG	_	_	_	_	_
8	approaches	_	_	NNS	_	_	_	_	_
9	that	_	_	WDT	_	_	_	_	_
10	leverage	_	_	VBP	_	_	_	_	_
11	artificial	_	_	JJ	_	_	_	_	_
12	intelligence	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	machine	_	_	NN	_	_	_	_	_
15	learning	_	_	NN	_	_	_	_	_
16	algorithms	_	_	NNS	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	improve	_	_	VB	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	utility	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	bioinformatics	_	_	NN	_	_	_	_	_
23	applications	_	_	NNS	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	cancer	_	_	NN	_	_	_	_	_
26	biology	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Importantly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	issue	_	_	NN	_	_	_	_	_
5	also	_	_	RB	_	_	_	_	_
6	addresses	_	_	VBZ	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	limitations	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	current	_	_	JJ	_	_	_	_	_
11	approaches	_	_	NNS	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	analyzing	_	_	VBG	_	_	_	_	_
14	high	_	_	JJ	_	_	_	_	_
15	throughput	_	_	NN	_	_	_	_	_
16	datasets	_	_	NNS	_	_	_	_	_
17	by	_	_	IN	_	_	_	_	_
18	providing	_	_	VBG	_	_	_	_	_
19	support	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	novel	_	_	JJ	_	_	_	_	_
22	methods	_	_	NNS	_	_	_	_	_
23	that	_	_	WDT	_	_	_	_	_
24	can	_	_	MD	_	_	_	_	_
25	be	_	_	VB	_	_	_	_	_
26	used	_	_	VBN	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	improve	_	_	VB	_	_	_	_	_
29	complex	_	_	JJ	_	_	_	_	_
30	multi-variable	_	_	JJ	_	_	_	_	_
31	analysis	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	order	_	_	NN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	help	_	_	VB	_	_	_	_	_
8	identify	_	_	VB	_	_	_	_	_
9	clinically	_	_	RB	_	_	_	_	_
10	meaningful	_	_	JJ	_	_	_	_	_
11	genes	_	_	NNS	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	Shen	_	_	NNP	_	_	_	_	_
14	et	_	_	FW	_	_	_	_	_
15	al.	_	_	FW	_	_	_	_	_


1	demonstrate	_	_	VB	_	_	_	_	_
2	how	_	_	WRB	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	implementation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	knockoff	_	_	NN	_	_	_	_	_
8	procedure	_	_	NN	_	_	_	_	_
9	can	_	_	MD	_	_	_	_	_
10	control	_	_	VB	_	_	_	_	_
11	false	_	_	JJ	_	_	_	_	_
12	discovery	_	_	NN	_	_	_	_	_
13	rates	_	_	NNS	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	next-generation	_	_	JJ	_	_	_	_	_
16	datasets	_	_	NNS	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	relatively	_	_	RB	_	_	_	_	_
19	small	_	_	JJ	_	_	_	_	_
20	sample	_	_	NN	_	_	_	_	_
21	sizes	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Additionally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	tools	_	_	NNS	_	_	_	_	_
4	were	_	_	VBD	_	_	_	_	_
5	developed	_	_	VBN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	validated	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	address	_	_	VB	_	_	_	_	_
10	complex	_	_	JJ	_	_	_	_	_
11	problems	_	_	NNS	_	_	_	_	_
12	ranging	_	_	VBG	_	_	_	_	_
13	from	_	_	IN	_	_	_	_	_
14	tumor	_	_	NN	_	_	_	_	_
15	heterogeneity	_	_	NN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	mutation	_	_	NN	_	_	_	_	_
18	signature	_	_	NN	_	_	_	_	_
19	analysis	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	intertumor	_	_	NN	_	_	_	_	_
5	heterogeneity	_	_	NN	_	_	_	_	_
6	scores	_	_	NNS	_	_	_	_	_
7	were	_	_	VBD	_	_	_	_	_
8	characterized	_	_	VBN	_	_	_	_	_
9	from	_	_	IN	_	_	_	_	_
10	>2800	_	_	CD	_	_	_	_	_
11	tumors	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	used	_	_	VBN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	identify	_	_	VB	_	_	_	_	_
16	genes	_	_	NNS	_	_	_	_	_
17	associated	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	high	_	_	JJ	_	_	_	_	_
20	heterogeneity	_	_	NN	_	_	_	_	_
21	including	_	_	VBG	_	_	_	_	_
22	histone	_	_	NN	_	_	_	_	_
23	methyltransferase	_	_	NN	_	_	_	_	_
24	SETD2	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	DNA	_	_	NN	_	_	_	_	_
27	methyltransferase	_	_	NN	_	_	_	_	_
28	DNMT3A	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	which	_	_	WDT	_	_	_	_	_
31	were	_	_	VBD	_	_	_	_	_
32	then	_	_	RB	_	_	_	_	_
33	validated	_	_	VBN	_	_	_	_	_
34	by	_	_	IN	_	_	_	_	_
35	CRISPR/CAS9	_	_	NNP	_	_	_	_	_
36	in	_	_	IN	_	_	_	_	_
37	experimental	_	_	JJ	_	_	_	_	_
38	systems	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Likewise	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	tool	_	_	NN	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	derived	_	_	VBN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	infer	_	_	VB	_	_	_	_	_
9	tumor	_	_	NN	_	_	_	_	_
10	RNA	_	_	NN	_	_	_	_	_
11	expression	_	_	NN	_	_	_	_	_
12	signatures	_	_	NNS	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	genes	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	copy	_	_	NN	_	_	_	_	_
17	loss	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	support	_	_	VB	_	_	_	_	_
20	gene-loss	_	_	NN	_	_	_	_	_
21	driven	_	_	VBN	_	_	_	_	_
22	biomarker	_	_	NN	_	_	_	_	_
23	analysis	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	weight-matrix	_	_	NN	_	_	_	_	_
29	based	_	_	VBN	_	_	_	_	_
30	approach	_	_	NN	_	_	_	_	_
31	was	_	_	VBD	_	_	_	_	_
32	used	_	_	VBN	_	_	_	_	_
33	to	_	_	TO	_	_	_	_	_
34	highlight	_	_	VB	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	distribution	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	APOBEC	_	_	NN	_	_	_	_	_
39	and	_	_	CC	_	_	_	_	_
40	AID-related	_	_	JJ	_	_	_	_	_
41	gene	_	_	NN	_	_	_	_	_
42	signatures	_	_	NNS	_	_	_	_	_
43	in	_	_	IN	_	_	_	_	_
44	multiple	_	_	JJ	_	_	_	_	_
45	cancers	_	_	NNS	_	_	_	_	_
46	that	_	_	WDT	_	_	_	_	_
47	drive	_	_	VBP	_	_	_	_	_
48	subsets	_	_	NNS	_	_	_	_	_
49	of	_	_	IN	_	_	_	_	_
50	the	_	_	DT	_	_	_	_	_
51	somatic	_	_	JJ	_	_	_	_	_
52	mutation	_	_	NN	_	_	_	_	_
53	spectra	_	_	NN	_	_	_	_	_
54	.	_	_	.	_	_	_	_	_


1	Together	_	_	RB	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	manuscripts	_	_	NNS	_	_	_	_	_
4	demonstrate	_	_	VBP	_	_	_	_	_
5	how	_	_	WRB	_	_	_	_	_
6	novel	_	_	JJ	_	_	_	_	_
7	tools	_	_	NNS	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	statistical	_	_	JJ	_	_	_	_	_
10	approaches	_	_	NNS	_	_	_	_	_
11	are	_	_	VBP	_	_	_	_	_
12	being	_	_	VBG	_	_	_	_	_
13	used	_	_	VBN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	refine	_	_	VB	_	_	_	_	_
16	analysis	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	large	_	_	JJ	_	_	_	_	_
19	next	_	_	JJ	_	_	_	_	_
20	generation	_	_	NN	_	_	_	_	_
21	sequencing	_	_	VBG	_	_	_	_	_
22	datasets	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Extending	_	_	VBG	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	concepts	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	Veronesi	_	_	NNP	_	_	_	_	_
6	et	_	_	FW	_	_	_	_	_
7	al.	_	_	FW	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	develop	_	_	VB	_	_	_	_	_
10	an	_	_	DT	_	_	_	_	_
11	R-script	_	_	NN	_	_	_	_	_
12	based	_	_	VBN	_	_	_	_	_
13	tool	_	_	NN	_	_	_	_	_
14	box	_	_	NN	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	efficient	_	_	JJ	_	_	_	_	_
17	analysis	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	gene	_	_	NN	_	_	_	_	_
20	signatures	_	_	NNS	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	diagnostic	_	_	JJ	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	prognostic	_	_	JJ	_	_	_	_	_
25	variable	_	_	NN	_	_	_	_	_
26	that	_	_	WDT	_	_	_	_	_
27	highlights	_	_	VBZ	_	_	_	_	_
28	how	_	_	WRB	_	_	_	_	_
29	tools	_	_	NNS	_	_	_	_	_
30	are	_	_	VBP	_	_	_	_	_
31	being	_	_	VBG	_	_	_	_	_
32	rapidly	_	_	RB	_	_	_	_	_
33	adapted	_	_	VBN	_	_	_	_	_
34	into	_	_	IN	_	_	_	_	_
35	easy-to-use	_	_	JJ	_	_	_	_	_
36	application	_	_	NN	_	_	_	_	_
37	packages	_	_	NNS	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	papers	_	_	NNS	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	series	_	_	NN	_	_	_	_	_
6	also	_	_	RB	_	_	_	_	_
7	demonstrate	_	_	VBP	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	potential	_	_	NN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	integrate	_	_	VB	_	_	_	_	_
12	large	_	_	JJ	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	diverse	_	_	JJ	_	_	_	_	_
15	datasets	_	_	NNS	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	use	_	_	VB	_	_	_	_	_
18	machine	_	_	NN	_	_	_	_	_
19	learning	_	_	NN	_	_	_	_	_
20	approaches	_	_	NNS	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	develop	_	_	VB	_	_	_	_	_
23	significantly	_	_	RB	_	_	_	_	_
24	improved	_	_	VBN	_	_	_	_	_
25	multi-variable	_	_	JJ	_	_	_	_	_
26	predictors	_	_	NNS	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	clinical	_	_	JJ	_	_	_	_	_
29	outcome	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	deep	_	_	JJ	_	_	_	_	_
5	learning	_	_	VBG	_	_	_	_	_
6	artificial	_	_	JJ	_	_	_	_	_
7	intelligence-based	_	_	JJ	_	_	_	_	_
8	approaches	_	_	NNS	_	_	_	_	_
9	were	_	_	VBD	_	_	_	_	_
10	shown	_	_	VBN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	highly	_	_	RB	_	_	_	_	_
14	effective	_	_	JJ	_	_	_	_	_
15	at	_	_	IN	_	_	_	_	_
16	integrating	_	_	VBG	_	_	_	_	_
17	genomic	_	_	JJ	_	_	_	_	_
18	data	_	_	NNS	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	multiple	_	_	JJ	_	_	_	_	_
21	sources	_	_	NNS	_	_	_	_	_
22	using	_	_	VBG	_	_	_	_	_
23	de-noising	_	_	VBG	_	_	_	_	_
24	auto-encoders	_	_	NNS	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	curate	_	_	VB	_	_	_	_	_
27	deep	_	_	JJ	_	_	_	_	_
28	features	_	_	NNS	_	_	_	_	_
29	associated	_	_	VBN	_	_	_	_	_
30	with	_	_	IN	_	_	_	_	_
31	breast	_	_	NN	_	_	_	_	_
32	cancer	_	_	NN	_	_	_	_	_
33	clinical	_	_	JJ	_	_	_	_	_
34	characteristics	_	_	NNS	_	_	_	_	_
35	and	_	_	CC	_	_	_	_	_
36	outcomes	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	artificial	_	_	JJ	_	_	_	_	_
4	intelligence-driven	_	_	JJ	_	_	_	_	_
5	classification	_	_	NN	_	_	_	_	_
6	techniques	_	_	NNS	_	_	_	_	_
7	were	_	_	VBD	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	used	_	_	VBN	_	_	_	_	_
10	on	_	_	IN	_	_	_	_	_
11	multiple	_	_	JJ	_	_	_	_	_
12	independent	_	_	JJ	_	_	_	_	_
13	colorectal	_	_	JJ	_	_	_	_	_
14	cancer	_	_	NN	_	_	_	_	_
15	datasets	_	_	NNS	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	identify	_	_	VB	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	verify	_	_	VB	_	_	_	_	_
20	biomarkers	_	_	NNS	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	diagnosis	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	prognosis	_	_	NN	_	_	_	_	_
25	that	_	_	WDT	_	_	_	_	_
26	may	_	_	MD	_	_	_	_	_
27	have	_	_	VB	_	_	_	_	_
28	important	_	_	JJ	_	_	_	_	_
29	implications	_	_	NNS	_	_	_	_	_
30	for	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	disease	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	another	_	_	DT	_	_	_	_	_
3	example	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	Taiwan	_	_	NNP	_	_	_	_	_
7	Cancer	_	_	NNP	_	_	_	_	_
8	Registry	_	_	NNP	_	_	_	_	_
9	database	_	_	NN	_	_	_	_	_
10	was	_	_	VBD	_	_	_	_	_
11	analyzed	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	evaluate	_	_	VB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	value	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	Wu	_	_	NNP	_	_	_	_	_
19	co-morbidity	_	_	NN	_	_	_	_	_
20	score	_	_	NN	_	_	_	_	_
21	for	_	_	IN	_	_	_	_	_
22	accuracy	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	assessing	_	_	VBG	_	_	_	_	_
25	curative-surgery-related	_	_	JJ	_	_	_	_	_
26	90-day	_	_	NN	_	_	_	_	_
27	mortality	_	_	NN	_	_	_	_	_
28	risk	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	overall	_	_	JJ	_	_	_	_	_
31	survival	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	patients	_	_	NNS	_	_	_	_	_
34	with	_	_	IN	_	_	_	_	_
35	locoregionally	_	_	RB	_	_	_	_	_
36	advanced	_	_	JJ	_	_	_	_	_
37	head	_	_	NN	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	neck	_	_	NN	_	_	_	_	_
40	cancer	_	_	NN	_	_	_	_	_
41	;	_	_	:	_	_	_	_	_
42	and	_	_	CC	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	in	_	_	IN	_	_	_	_	_
45	an	_	_	DT	_	_	_	_	_
46	alternative	_	_	JJ	_	_	_	_	_
47	approach	_	_	NN	_	_	_	_	_
48	,	_	_	,	_	_	_	_	_
49	Ferroni	_	_	NNP	_	_	_	_	_
50	et	_	_	FW	_	_	_	_	_
51	al.	_	_	FW	_	_	_	_	_
52	demonstrate	_	_	VB	_	_	_	_	_
53	the	_	_	DT	_	_	_	_	_
54	utility	_	_	NN	_	_	_	_	_
55	of	_	_	IN	_	_	_	_	_
56	using	_	_	VBG	_	_	_	_	_
57	machine	_	_	NN	_	_	_	_	_
58	learning-driven	_	_	JJ	_	_	_	_	_
59	decision	_	_	NN	_	_	_	_	_
60	support	_	_	NN	_	_	_	_	_
61	systems	_	_	NNS	_	_	_	_	_
62	to	_	_	TO	_	_	_	_	_
63	extract	_	_	VB	_	_	_	_	_
64	data	_	_	NNS	_	_	_	_	_
65	from	_	_	IN	_	_	_	_	_
66	electronic	_	_	JJ	_	_	_	_	_
67	health	_	_	NN	_	_	_	_	_
68	records	_	_	NNS	_	_	_	_	_
69	and	_	_	CC	_	_	_	_	_
70	refine	_	_	VB	_	_	_	_	_
71	prognostic	_	_	JJ	_	_	_	_	_
72	variables	_	_	NNS	_	_	_	_	_
73	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	an	_	_	DT	_	_	_	_	_
3	alternative	_	_	JJ	_	_	_	_	_
4	approach	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	understand	_	_	VB	_	_	_	_	_
9	how	_	_	WRB	_	_	_	_	_
10	gene	_	_	NN	_	_	_	_	_
11	sets	_	_	NNS	_	_	_	_	_
12	may	_	_	MD	_	_	_	_	_
13	correlate	_	_	VB	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	outcome	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	Locati	_	_	NNP	_	_	_	_	_
18	et	_	_	FW	_	_	_	_	_
19	al.	_	_	FW	_	_	_	_	_
20	utilized	_	_	VBN	_	_	_	_	_
21	self-organizing	_	_	JJ	_	_	_	_	_
22	map	_	_	NN	_	_	_	_	_
23	approaches	_	_	NNS	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	curate	_	_	VB	_	_	_	_	_
26	publicly	_	_	RB	_	_	_	_	_
27	available	_	_	JJ	_	_	_	_	_
28	HPV+	_	_	NNP	_	_	_	_	_
29	cancer	_	_	NN	_	_	_	_	_
30	data	_	_	NNS	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	inferred	_	_	VBN	_	_	_	_	_
33	gene	_	_	NN	_	_	_	_	_
34	signatures	_	_	NNS	_	_	_	_	_
35	associated	_	_	VBN	_	_	_	_	_
36	with	_	_	IN	_	_	_	_	_
37	three	_	_	CD	_	_	_	_	_
38	biological	_	_	JJ	_	_	_	_	_
39	subtypes	_	_	NNS	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	the	_	_	DT	_	_	_	_	_
42	disease	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Novel	_	_	JJ	_	_	_	_	_
2	datasets	_	_	NNS	_	_	_	_	_
3	comparing	_	_	VBG	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	molecular	_	_	JJ	_	_	_	_	_
6	composition	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	primary	_	_	JJ	_	_	_	_	_
9	colorectal	_	_	JJ	_	_	_	_	_
10	cancer	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	brain	_	_	NN	_	_	_	_	_
13	metastases	_	_	NNS	_	_	_	_	_
14	were	_	_	VBD	_	_	_	_	_
15	also	_	_	RB	_	_	_	_	_
16	generated	_	_	VBN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	an	_	_	DT	_	_	_	_	_
3	interesting	_	_	JJ	_	_	_	_	_
4	informatics	_	_	NN	_	_	_	_	_
5	approach	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	analysis	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	steroid	_	_	NN	_	_	_	_	_
10	hormone-related	_	_	JJ	_	_	_	_	_
11	gene	_	_	NN	_	_	_	_	_
12	sets	_	_	NNS	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	publicly	_	_	RB	_	_	_	_	_
15	available	_	_	JJ	_	_	_	_	_
16	data	_	_	NNS	_	_	_	_	_
17	identified	_	_	VBN	_	_	_	_	_
18	steroidogenic	_	_	JJ	_	_	_	_	_
19	acute	_	_	JJ	_	_	_	_	_
20	regulatory	_	_	JJ	_	_	_	_	_
21	protein	_	_	NN	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	potential	_	_	JJ	_	_	_	_	_
25	prognostic	_	_	JJ	_	_	_	_	_
26	biomarker	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	breast	_	_	NN	_	_	_	_	_
29	cancer	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Likewise	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	meta-analysis	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	GEO	_	_	NNP	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	TCGA	_	_	NNP	_	_	_	_	_
9	miRNA	_	_	NN	_	_	_	_	_
10	datasets	_	_	NNS	_	_	_	_	_
11	led	_	_	VBD	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	prioritization	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	candidate	_	_	NN	_	_	_	_	_
17	biomarkers	_	_	NNS	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	prognosis	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	overall	_	_	JJ	_	_	_	_	_
22	survival	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	oral	_	_	JJ	_	_	_	_	_
25	cancer	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Machine	_	_	NN	_	_	_	_	_
2	learning	_	_	NN	_	_	_	_	_
3	approaches	_	_	NNS	_	_	_	_	_
4	were	_	_	VBD	_	_	_	_	_
5	similarly	_	_	RB	_	_	_	_	_
6	used	_	_	VBN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	prioritize	_	_	VB	_	_	_	_	_
9	relevant	_	_	JJ	_	_	_	_	_
10	miRNAs	_	_	NNS	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	validate	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	high	_	_	JJ	_	_	_	_	_
15	performance	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	highly	_	_	RB	_	_	_	_	_
18	ranked	_	_	VBN	_	_	_	_	_
19	miRNAs	_	_	NNS	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	classification	_	_	NN	_	_	_	_	_
22	models	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	suggesting	_	_	VBG	_	_	_	_	_
25	that	_	_	IN	_	_	_	_	_
26	prioritization	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	targets	_	_	NNS	_	_	_	_	_
29	from	_	_	IN	_	_	_	_	_
30	expression	_	_	NN	_	_	_	_	_
31	data	_	_	NNS	_	_	_	_	_
32	is	_	_	VBZ	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	highly	_	_	RB	_	_	_	_	_
35	effective	_	_	JJ	_	_	_	_	_
36	strategy	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Analysis	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	miRNA	_	_	NN	_	_	_	_	_
4	data	_	_	NNS	_	_	_	_	_
5	using	_	_	VBG	_	_	_	_	_
6	an	_	_	DT	_	_	_	_	_
7	observed	_	_	VBN	_	_	_	_	_
8	survival	_	_	NN	_	_	_	_	_
9	interval	_	_	NN	_	_	_	_	_
10	was	_	_	VBD	_	_	_	_	_
11	reported	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	overcome	_	_	VB	_	_	_	_	_
14	issues	_	_	NNS	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	clinical	_	_	JJ	_	_	_	_	_
17	outcome	_	_	NN	_	_	_	_	_
18	associations	_	_	NNS	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Collectively	_	_	RB	_	_	_	_	_
2	suggesting	_	_	VBG	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	potential	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	these	_	_	DT	_	_	_	_	_
7	approaches	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	this	_	_	DT	_	_	_	_	_
10	new	_	_	JJ	_	_	_	_	_
11	era	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	machine	_	_	NN	_	_	_	_	_
14	learning	_	_	NN	_	_	_	_	_
15	approaches	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	additional	_	_	JJ	_	_	_	_	_
4	analysis	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	similar	_	_	JJ	_	_	_	_	_
7	datasets	_	_	NNS	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	highlighted	_	_	VBD	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	role	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	detailed	_	_	JJ	_	_	_	_	_
14	characterization	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	clinical	_	_	JJ	_	_	_	_	_
17	characteristics	_	_	NNS	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	avoiding	_	_	VBG	_	_	_	_	_
20	biological	_	_	JJ	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	clinical	_	_	JJ	_	_	_	_	_
24	outcome	_	_	NN	_	_	_	_	_
25	analysis	_	_	NN	_	_	_	_	_
26	bias	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	large	_	_	JJ	_	_	_	_	_
29	dataset	_	_	NN	_	_	_	_	_
30	analysis	_	_	NN	_	_	_	_	_
31	was	_	_	VBD	_	_	_	_	_
32	well	_	_	RB	_	_	_	_	_
33	demonstrated	_	_	VBN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	analysis	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	pancreatic	_	_	JJ	_	_	_	_	_
39	cancer	_	_	NN	_	_	_	_	_
40	TCGA	_	_	NNP	_	_	_	_	_
41	data	_	_	NNS	_	_	_	_	_
42	by	_	_	IN	_	_	_	_	_
43	Nicolle	_	_	NNP	_	_	_	_	_
44	et	_	_	FW	_	_	_	_	_
45	al.	_	_	FW	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	More	_	_	RBR	_	_	_	_	_
2	broadly	_	_	RB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	machine	_	_	NN	_	_	_	_	_
5	learning-driven	_	_	JJ	_	_	_	_	_
6	informatics	_	_	NNS	_	_	_	_	_
7	approaches	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	were	_	_	VBD	_	_	_	_	_
11	demonstrated	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	have	_	_	VB	_	_	_	_	_
14	utility	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	improving	_	_	VBG	_	_	_	_	_
17	statistical	_	_	JJ	_	_	_	_	_
18	analysis	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	integrated	_	_	VBN	_	_	_	_	_
21	histopathologic	_	_	JJ	_	_	_	_	_
22	datasets	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	were	_	_	VBD	_	_	_	_	_
25	implemented	_	_	VBN	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	analyze	_	_	VB	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	TCGA	_	_	NNP	_	_	_	_	_
30	lung	_	_	NN	_	_	_	_	_
31	adenocarcinoma	_	_	NN	_	_	_	_	_
32	dataset	_	_	NN	_	_	_	_	_
33	as	_	_	IN	_	_	_	_	_
34	an	_	_	DT	_	_	_	_	_
35	alternative	_	_	JJ	_	_	_	_	_
36	approach	_	_	NN	_	_	_	_	_
37	to	_	_	TO	_	_	_	_	_
38	modeling	_	_	VBG	_	_	_	_	_
39	outcomes	_	_	NNS	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Furthermore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	using	_	_	VBG	_	_	_	_	_
4	both	_	_	CC	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	lung	_	_	NN	_	_	_	_	_
7	adenocarcinoma	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	hepatocellular	_	_	JJ	_	_	_	_	_
10	carcinoma	_	_	NN	_	_	_	_	_
11	datasets	_	_	NNS	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	analyze	_	_	VB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	utility	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	integrated	_	_	VBN	_	_	_	_	_
18	gene	_	_	NN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	imaging	_	_	NN	_	_	_	_	_
21	data	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	multiple	_	_	JJ	_	_	_	_	_
24	individual	_	_	JJ	_	_	_	_	_
25	genes	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	conditional	_	_	JJ	_	_	_	_	_
28	on	_	_	IN	_	_	_	_	_
29	imaging	_	_	VBG	_	_	_	_	_
30	features	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	were	_	_	VBD	_	_	_	_	_
33	shown	_	_	VBN	_	_	_	_	_
34	to	_	_	TO	_	_	_	_	_
35	drive	_	_	VB	_	_	_	_	_
36	significant	_	_	JJ	_	_	_	_	_
37	improvement	_	_	NN	_	_	_	_	_
38	in	_	_	IN	_	_	_	_	_
39	prognosis	_	_	NN	_	_	_	_	_
40	modeling	_	_	NN	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	improvements	_	_	NNS	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	integrated	_	_	VBN	_	_	_	_	_
5	multi-feature	_	_	JJ	_	_	_	_	_
6	image	_	_	NN	_	_	_	_	_
7	analysis	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	molecular	_	_	JJ	_	_	_	_	_
10	analysis	_	_	NN	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	outcome	_	_	NN	_	_	_	_	_
13	modeling	_	_	NN	_	_	_	_	_
14	suggest	_	_	VBP	_	_	_	_	_
15	that	_	_	IN	_	_	_	_	_
16	complex	_	_	JJ	_	_	_	_	_
17	models	_	_	NNS	_	_	_	_	_
18	incorporating	_	_	VBG	_	_	_	_	_
19	diverse	_	_	JJ	_	_	_	_	_
20	variables	_	_	NNS	_	_	_	_	_
21	may	_	_	MD	_	_	_	_	_
22	be	_	_	VB	_	_	_	_	_
23	key	_	_	JJ	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	making	_	_	VBG	_	_	_	_	_
26	substantial	_	_	JJ	_	_	_	_	_
27	improvements	_	_	NNS	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	clinical	_	_	JJ	_	_	_	_	_
30	outcome	_	_	NN	_	_	_	_	_
31	models	_	_	NNS	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	future	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_

